Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06SEA
|
||||
Former ID |
DIB000190
|
||||
Drug Name |
CX-7000
|
||||
Synonyms |
Second generation CK2 inhibitors (cancer), Cylene
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543439] | ||
Company |
Cylene Pharmaceuticals Inc
|
||||
Target and Pathway | |||||
Target(s) | Casein kinase II, alpha chain | Target Info | Inhibitor | [543439] | |
NetPath Pathway | FSH Signaling Pathway | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
Atypical NF-kappaB pathway | |||||
DNA-PK pathway in nonhomologous end joining | |||||
Presenilin action in Notch and Wnt signaling | |||||
Role of Calcineurin-dependent NFAT signaling in lymphocytes | |||||
E-cadherin signaling in the nascent adherens junction | |||||
Lissencephaly gene (LIS1) in neuronal migration and development | |||||
PDGFR-alpha signaling pathway | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
Alpha-synuclein signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.